A vaccination campaign aimed at beating an outbreak of Ebola in Congo began on Monday in the port city of Mbandaka, where four cases of the deadly disease have been confirmed. Use of the VSV-EBOV shot – an experimental vaccine developed by Merck – marks a “paradigm shift” in how[…]